Patent directory · USPTO A61K / A61P
Patents matching “neuroprotective”
21 pharma patents match "neuroprotective" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 21 pharmaceutical patents matching "neuroprotective" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11974988
Neuroprotective compositions and methods of using the same
granted -
US 11970521
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
granted -
US 11872312
Neuroprotective liposome compositions and methods for treatment of stroke
granted -
US 11471502
Neuroprotective peptide
granted -
US 11414379
SPAK kinase inhibitors as neuroprotective agents
granted -
US 11273130
Methods of delivering a neuroprotective polypeptide to the central nervous system
granted -
US 11147795
Neuroprotective compounds and methods of use
granted -
US 10995061
SPAK kinase inhibitors as neuroprotective agents
granted -
US 10973764
Neuroprotective liposome compositions and methods for treatment of stroke
granted -
US 10369103
Neuroprotective liposome compositions and methods for treatment of stroke
granted -
US 9902713
Neuroprotective compounds and use thereof
granted -
US 9645139
Neuroprotective chemicals and methods for identifying and using same
granted -
US 9243281
Neuroprotective chemicals and methods for identifying and using same
granted -
US 9205119
Neuroprotective compositions and methods
granted -
US 8350077
Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity
granted -
US 8329719
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
granted -
US 8058268
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
granted -
US 8030493
Monovalent and divalent salts of N-(5-hydroxynicotinoil) -L-glutamic acid exhibiting psychotropic (antidepressant and anxiolytic), neuroprotective, geroprotective and cerebroprotective action
granted -
US 7022882
NMDA receptor channel blocker with neuroprotective activity
expired -
US 6410537
Compositions having neuroprotective and analgesic activity
expired -
US 6046200
Compositions having neuroprotective and analgesic activity
expired